{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T02:05:35Z","timestamp":1794708335325,"version":"4.9.1"},"reference-count":78,"publisher":"Xia & He Publishing","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["gene expr"],"published-print":{"date-parts":[[2018,3,21]]},"abstract":"<jats:p>Nonalcoholic fatty liver disease (NAFLD) is a disease of increasing interest, as its prevalence is on the rise. NAFLD has been linked to metabolic syndrome, which is becoming more common due to the Western diet. Because NAFLD can lead to cirrhosis and related complications including hepatocellular carcinoma, the increasing prevalence is concerning, and medical therapy aimed at treating NAFLD is of great interest. Researchers studying the effects of medical therapy on NAFLD use dietary mouse models. The two main types of mouse model diets are the methionine- and choline-deficient (MCD) diet and the Western-like diet (WD). Although both induce NAFLD, the mechanisms are very different. We reviewed several studies conducted within the last 5 years that used MCD diet or WD mouse models in order to mimic this disease in a way most similar to humans. The MCD diet inconsistently induces NAFLD and fibrosis and does not completely induce metabolic syndrome. Thus, the clinical significance of the MCD diet is questionable. In contrast, WD mouse models consisting of high fat, cholesterol, and a combination of high-fructose corn syrup, sucrose, fructose, or glucose not only lead to metabolic syndrome but also induce NAFLD with fibrosis, making these choices most suitable for research.<\/jats:p>","DOI":"10.3727\/105221617x15093707969658","type":"journal-article","created":{"date-parts":[[2017,11,2]],"date-time":"2017-11-02T21:17:20Z","timestamp":1509657440000},"page":"5-17","source":"Crossref","is-referenced-by-count":121,"title":["Updates on Dietary Models of Nonalcoholic Fatty Liver Disease: Current Studies and Insights"],"prefix":"10.14218","volume":"18","author":[{"given":"Kristen","family":"Stephenson","sequence":"first","affiliation":[{"name":"Scott & White Digestive Disease Research Center, Baylor Scott & White Health, Temple, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey","family":"Kennedy","sequence":"additional","affiliation":[{"name":"Research, Central Texas Veterans Health Care System, Temple, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Hargrove","sequence":"additional","affiliation":[{"name":"Department of Medicine, Texas A&M Health Science Center, Temple, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Demieville","sequence":"additional","affiliation":[{"name":"Research, Central Texas Veterans Health Care System, Temple, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Thomson","sequence":"additional","affiliation":[{"name":"Research, Central Texas Veterans Health Care System, Temple, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Alpini","sequence":"additional","affiliation":[{"name":"Scott & White Digestive Disease Research Center, Baylor Scott & White Health, Temple, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Francis","sequence":"additional","affiliation":[{"name":"Scott & White Digestive Disease Research Center, Baylor Scott & White Health, Temple, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5334","reference":[{"issue":"3","key":"b1","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","article-title":"Systematic review: The epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults","volume":"34","year":"2011","journal-title":"Aliment Pharmacol Ther."},{"issue":"5","key":"b2","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/j.1572-0241.2003.07486.x","article-title":"The prevalence and etiology of elevated aminotransferase levels in the United States","volume":"98","year":"2003","journal-title":"Am J Gastroenterol."},{"issue":"6","key":"b3","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1053\/jhep.2002.33324","article-title":"Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis","volume":"35","year":"2002","journal-title":"Hepatology"},{"issue":"1","key":"b4","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/j.gastro.2010.09.038","article-title":"Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: A prospective study","volume":"140","year":"2011","journal-title":"Gastroenterology"},{"issue":"6","key":"b5","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","article-title":"Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity","volume":"116","year":"1999","journal-title":"Gastroenterology"},{"issue":"5","key":"b6","first-page":"767","article-title":"Cirrhosis and chronic liver failure: Part II. Complications and treatment","volume":"74","year":"2006","journal-title":"Am Fam Physician"},{"issue":"4","key":"b7","first-page":"1295","article-title":"Non-alcoholic fatty liver disease\u2014Clinical and histopathological aspects","volume":"57","year":"2016","journal-title":"Rom J Morphol Embryol."},{"issue":"2","key":"b8","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1053\/jhep.2002.30692","article-title":"NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome","volume":"35","year":"2002","journal-title":"Hepatology"},{"issue":"5","key":"b9","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","year":"2005","journal-title":"J Clin Invest."},{"issue":"4","key":"b10","first-page":"578","article-title":"The spectrum expanded: Cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease","volume":"40","year":"2004","journal-title":"J Hepatol."},{"issue":"5","key":"b11","doi-asserted-by":"crossref","first-page":"774","DOI":"10.3390\/ijms17050774","article-title":"The natural course of non-alcoholic fatty liver disease","volume":"17","year":"2016","journal-title":"Int J Mol Sci."},{"issue":"2","key":"b12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/qjmed\/hcp158","article-title":"Pathogenesis of non-alcoholic fatty liver disease","volume":"103","year":"2010","journal-title":"QJM"},{"issue":"4","key":"b13","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","article-title":"Steatohepatitis: A tale of two \u201chits\u201d?","volume":"114","year":"1998","journal-title":"Gastroenterology"},{"issue":"5","key":"b14","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/jcp.31.5.395","article-title":"The morphology of cirrhosis. Recommendations on definition, nomenclature, and classification by a working group sponsored by the World Health Organization","volume":"31","year":"1978","journal-title":"J Clin Pathol."},{"issue":"6","key":"b15","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.cgh.2011.03.020","article-title":"Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008","volume":"9","year":"2011","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"11","key":"b16","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.2337\/diacare.28.11.2745","article-title":"Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S.","volume":"28","year":"2005","journal-title":"Diabetes Care"},{"issue":"10","key":"b17","doi-asserted-by":"crossref","first-page":"722","DOI":"10.7326\/0003-4819-143-10-200511150-00009","article-title":"The metabolic syndrome as a predictor of nonalcoholic fatty liver disease","volume":"143","year":"2005","journal-title":"Ann Intern Med."},{"issue":"4","key":"b18","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1053\/jhep.2003.50161","article-title":"Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome","volume":"37","year":"2003","journal-title":"Hepatology"},{"issue":"2","key":"b19","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1017\/S095442241600007X","article-title":"Current evidence on the association of the metabolic syndrome and dietary patterns in a global perspective","volume":"29","year":"2016","journal-title":"Nutr Res Rev."},{"issue":"3","key":"b20","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jnutbio.2014.11.002","article-title":"Saturated fat and cholesterol are critical to inducing murine metabolic syndrome with robust nonalcoholic steatohepatitis","volume":"26","year":"2015","journal-title":"J Nutr Biochem."},{"issue":"24","key":"b21","doi-asserted-by":"crossref","first-page":"18528","DOI":"10.1074\/jbc.M109.099333","article-title":"Specific contribution of methionine and choline in nutritional nonalcoholic steatohepatitis: Impact on mitochondrial S-adenosyl-L-methionine and glutathione","volume":"285","year":"2010","journal-title":"J Biol Chem."},{"issue":"2","key":"b22","doi-asserted-by":"crossref","first-page":"e0147745","DOI":"10.1371\/journal.pone.0147745","article-title":"Hepatoprotective effect and synergism of bisdemethoycurcumin against MCD diet-induced nonalcoholic fatty liver disease in mice","volume":"11","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"b23","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/hep.26749","article-title":"Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH","volume":"59","year":"2014","journal-title":"Hepatology"},{"issue":"11","key":"b24","doi-asserted-by":"crossref","first-page":"e112327","DOI":"10.1371\/journal.pone.0112327","article-title":"Pharmacological inhibition of the chemokine CXCL16 diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury","volume":"9","year":"2014","journal-title":"PLoS One"},{"key":"b25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/liv.13301","article-title":"Pathology of non-alcoholic fatty liver disease","volume":"37","year":"2017","journal-title":"Liver Int."},{"key":"b26","doi-asserted-by":"crossref","first-page":"125380","DOI":"10.1155\/2015\/125380","article-title":"LUBAC formation is impaired in the livers of mice with MCD-dependent nonalcoholic steatohepatitis","volume":"2015","year":"2015","journal-title":"Mediators Inflamm."},{"issue":"3","key":"b27","doi-asserted-by":"crossref","first-page":"663","DOI":"10.3892\/etm.2013.1461","article-title":"Comparison between the efficacies of curcumin and puerarin in C57BL\/6 mice with steatohepatitis induced by a methionine- and choline-deficient diet","volume":"7","year":"2014","journal-title":"Exp Ther Med."},{"issue":"48","key":"b28","doi-asserted-by":"crossref","first-page":"40161","DOI":"10.1074\/jbc.M112.417014","article-title":"Kuppfer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-alpha production","volume":"287","year":"2012","journal-title":"J Biol Chem."},{"issue":"3","key":"b29","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1042\/CS20150405","article-title":"The balance between IL-17 and IL-22 produced by liver-infiltrating T-helper cells critically controls NASH development in mice","volume":"130","year":"2016","journal-title":"Clin Sci. (Lond)"},{"issue":"5","key":"b30","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jhep.2014.11.034","article-title":"Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management","volume":"62","year":"2015","journal-title":"J Hepatol."},{"issue":"12","key":"b31","first-page":"2683","article-title":"Morphological and functional characterization of non-alcoholic fatty liver disease induced by a methionine-choline-deficient diet in C57BL\/6 mice","volume":"6","year":"2013","journal-title":"Int J Clin Exp Pathol."},{"issue":"1","key":"b32","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/hep.23276","article-title":"Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis","volume":"51","year":"2010","journal-title":"Hepatology"},{"issue":"5","key":"b33","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.2337\/diacare.28.5.1222","article-title":"Associations between liver histology and severity of the metabolic syndrome in subjects with nonalcoholic fatty liver disease","volume":"28","year":"2005","journal-title":"Diabetes Care"},{"issue":"3","key":"b34","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1136\/gutjnl-2011-300304","article-title":"Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury","volume":"61","year":"2012","journal-title":"Gut"},{"issue":"4","key":"b35","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3892\/ijmm.2015.2092","article-title":"MicroRNA profiles following metformin treatment in a mouse model of non-alcoholic steatohepatitis","volume":"35","year":"2015","journal-title":"Int J Mol Med."},{"issue":"10","key":"b36","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.3945\/jn.112.165274","article-title":"Quercetin treatment ameliorates inflammation and fibrosis in mice with nonalcoholic steatohepatitis","volume":"142","year":"2012","journal-title":"J Nutr."},{"issue":"12","key":"b37","doi-asserted-by":"crossref","first-page":"G911","DOI":"10.1152\/ajpgi.00225.2013","article-title":"Lactobacillus casei strain Shirota protects against nonalcoholic steatohepatitis development in a rodent model","volume":"305","year":"2013","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"issue":"47","key":"b38","doi-asserted-by":"crossref","first-page":"17839","DOI":"10.3748\/wjg.v20.i47.17839","article-title":"Elevated free cholesterol in a p62 overexpression model of non-alcoholic steatohepatitis","volume":"20","year":"2014","journal-title":"World J Gastroenterol."},{"issue":"1","key":"b39","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.bbrc.2014.04.048","article-title":"Bile acids override steatosis in farnesoid X receptor deficient mice in a model of non-alcoholic steatohepatitis","volume":"448","year":"2014","journal-title":"Biochem Biophys Res Commun."},{"issue":"4","key":"b40","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/0016-5085(94)90235-6","article-title":"Nonalcoholic steatohepatitis: An expanded clinical entity","volume":"107","year":"1994","journal-title":"Gastroenterology"},{"issue":"11","key":"b41","first-page":"626","article-title":"Alkaline phosphatase: Can it be considered as an indicator of liver fibrosis in non-alcoholic steatohepatitis with type 2 diabetes?","volume":"112","year":"2011","journal-title":"Bratisl Lek Listy"},{"issue":"6","key":"b42","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1053\/jhep.2003.50229","article-title":"Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values","volume":"37","year":"2003","journal-title":"Hepatology"},{"issue":"4","key":"b43","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/j.1572-0241.1999.01006.x","article-title":"The ratio of aspartate aminotransferase to alanine aminotransferase: Potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease","volume":"94","year":"1999","journal-title":"Am J Gastroenterol."},{"key":"b44","doi-asserted-by":"crossref","first-page":"12931","DOI":"10.1038\/srep12931","article-title":"Seven weeks of Western diet in apolipoprotein-E-deficient mice induce metabolic syndrome and non-alcoholic steatohepatitis with liver fibrosis","volume":"5","year":"2015","journal-title":"Sci Rep."},{"issue":"1","key":"b45","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jhep.2003.09.020","article-title":"The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance","volume":"40","year":"2004","journal-title":"J Hepatol."},{"issue":"5","key":"b46","doi-asserted-by":"crossref","first-page":"e0127991","DOI":"10.1371\/journal.pone.0127991","article-title":"Mouse models of diet-induced nonalcoholic steatohepatitis reproduce the heterogeneity of the human disease","volume":"10","year":"2015","journal-title":"PLoS One"},{"issue":"17","key":"b47","doi-asserted-by":"crossref","first-page":"11482","DOI":"10.1073\/pnas.132384699","article-title":"Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity","volume":"99","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"b48","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.jnutbio.2014.06.012","article-title":"Interstrain differences in the progression of nonalcoholic steatohepatitis to fibrosis in mice are associated with altered hepatic iron metabolism","volume":"25","year":"2014","journal-title":"J Nutr Biochem."},{"issue":"11","key":"b49","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.1096\/fj.12-209569","article-title":"Interstrain differences in the severity of liver injury induced by a choline- and folate-deficient diet in mice are associated with dysregulation of genes involved in lipid metabolism","volume":"26","year":"2012","journal-title":"FASEB J."},{"issue":"1","key":"b50","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/hep.25641","article-title":"Interstrain differences in liver injury and one-carbon metabolism in alcohol-fed mice","volume":"56","year":"2012","journal-title":"Hepatology"},{"issue":"2","key":"b51","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1440-1746.2007.05150.x","article-title":"Interstrain differences in susceptibility to non-alcoholic steatohepatitis","volume":"23","year":"2008","journal-title":"J Gastroenterol Hepatol."},{"issue":"8","key":"b52","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/j.1478-3231.2006.01314.x","article-title":"Quantitative trait loci analysis of mice administered the methionine-choline deficient dietary model of experimental steatohepatitis","volume":"26","year":"2006","journal-title":"Liver Int."},{"key":"b53","first-page":"379","article-title":"Hepatic function and the cardiometabolic syndrome","volume":"6","year":"2013","journal-title":"Diabetes Metab Syndr Obes."},{"issue":"2","key":"b54","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1210\/en.2005-0570","article-title":"Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis","volume":"147","year":"2006","journal-title":"Endocrinology"},{"issue":"5","key":"b55","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2174\/157016111205140926155515","article-title":"Editorial: Exploring lipid-related treatment options for the treatment of NASH","volume":"12","year":"2014","journal-title":"Curr Vasc Pharmacol."},{"issue":"44","key":"b56","doi-asserted-by":"crossref","first-page":"42774","DOI":"10.1074\/jbc.M306022200","article-title":"Cholesterol and cholate components of an atherogenic diet induce distinct stages of hepatic inflammatory gene expression","volume":"278","year":"2003","journal-title":"J Biol Chem."},{"issue":"9\u201310","key":"b57","first-page":"473","article-title":"Modeling progressive non-alcoholic fatty liver disease in the laboratory mouse","volume":"25","year":"2014","journal-title":"Mamm Genome"},{"key":"b58","first-page":"574832","article-title":"Nonalcoholic steatohepatitis: A search for factual animal models","volume":"2015","year":"2015","journal-title":"Biomed Res Int."},{"issue":"1","key":"b59","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000282097","article-title":"Animal models of non-alcoholic steatohepatitis: Of mice and man","volume":"28","year":"2010","journal-title":"Dig Dis."},{"key":"b60","doi-asserted-by":"crossref","first-page":"25747","DOI":"10.1038\/srep25747","article-title":"Ces3\/TGH deficiency attenuates steatohepatitis","volume":"6","year":"2016","journal-title":"Sci Rep."},{"issue":"6","key":"b61","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/ajcn\/57.6.875","article-title":"Dietary fat and serum lipids: An evaluation of the experimental data","volume":"57","year":"1993","journal-title":"Am J Clin Nutr."},{"issue":"2","key":"b62","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/ajcn\/40.2.351","article-title":"Serum cholesterol response to dietary cholesterol","volume":"40","year":"1984","journal-title":"Am J Clin Nutr."},{"issue":"11","key":"b63","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1161\/01.STR.31.11.2751","article-title":"AHA dietary guidelines: Revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association","volume":"31","year":"2000","journal-title":"Stroke"},{"issue":"1","key":"b64","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1055\/s-2006-927394","article-title":"Carbohydrate metabolism and the liver: Actual aspects from physiology and disease","volume":"45","year":"2007","journal-title":"Z Gastroenterol."},{"issue":"10","key":"b65","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/ajcn\/27.10.1043","article-title":"Sucrose and various carbohydrate-containing foods and serum lipids in man","volume":"27","year":"1974","journal-title":"Am J Clin Nutr."},{"issue":"4","key":"b66","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/labinvest.2014.3","article-title":"Increased expression of c-Jun in nonalcoholic fatty liver disease","volume":"94","year":"2014","journal-title":"Lab Invest."},{"issue":"1","key":"b67","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jhep.2016.08.024","article-title":"Inhibiting poly ADP-ribosylation increases fatty acid oxidation and protects against fatty liver disease","volume":"66","year":"2017","journal-title":"J Hepatol."},{"issue":"2","key":"b68","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/cpmo.1","article-title":"Development of a representative mouse model with nonalcoholic steatohepatitis","volume":"6","year":"2016","journal-title":"Curr Protoc Mouse Biol."},{"key":"b69","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jnutbio.2016.09.010","article-title":"High-fructose corn syrup-55 consumption alters hepatic lipid metabolism and promotes triglyceride accumulation","volume":"39","year":"2017","journal-title":"J Nutr Biochem."},{"issue":"4","key":"b70","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1002\/hep.26491","article-title":"Advanced glycation endproducts induce fibrogenic activity in nonalcoholic steatohepatitis by modulating TNF-alpha-converting enzyme activity in mice","volume":"58","year":"2013","journal-title":"Hepatology"},{"key":"b71","doi-asserted-by":"crossref","first-page":"e2096","DOI":"10.1038\/cddis.2016.19","article-title":"Caspase-2 promotes obesity, the metabolic syndrome and nonalcoholic fatty liver disease","volume":"7","year":"2016","journal-title":"Cell Death Dis."},{"key":"b72","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jnutbio.2016.10.007","article-title":"A diet-induced Sprague-Dawley rat model of nonalcoholic steatohepatitis-related cirrhosis","volume":"40","year":"2017","journal-title":"J Nutr Biochem."},{"issue":"1","key":"b73","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1210\/er.2008-0033","article-title":"Hypothesis: Could excessive fructose intake and uric acid cause type 2 diabetes?","volume":"30","year":"2009","journal-title":"Endocr Rev."},{"issue":"5","key":"b74","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrgastro.2010.41","article-title":"The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome","volume":"7","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol."},{"issue":"6","key":"b75","doi-asserted-by":"crossref","first-page":"E418","DOI":"10.1152\/ajpendo.00319.2015","article-title":"Metabolic phenotype and adipose and liver features in a high-fat Western diet-induced mouse model of obesity-linked NAFLD","volume":"310","year":"2016","journal-title":"Am J Physiol Endocrinol Metab."},{"issue":"1","key":"b76","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/path.4829","article-title":"Animal models of non-alcoholic fatty liver disease: Current perspectives and recent advances","volume":"241","year":"2017","journal-title":"J Pathol."},{"issue":"3","key":"b77","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s12328-017-0732-5","article-title":"Significance of genetic polymorphisms in patients with nonalcoholic fatty liver disease","volume":"10","year":"2017","journal-title":"Clin J Gastroenterol."},{"issue":"4","key":"b78","doi-asserted-by":"crossref","first-page":"836","DOI":"10.3945\/ajcn.110.000141","article-title":"Trends in carbohydrate, fat, and protein intakes and association with energy intake in normal-weight, overweight, and obese individuals: 1971-2006","volume":"93","year":"2011","journal-title":"Am J Clin Nutr."}],"container-title":["Gene Expression"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ingentaconnect.com\/content\/cog\/ge\/2018\/00000018\/00000001\/art00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T18:24:52Z","timestamp":1783707892000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ingentaconnect.com\/content\/10.3727\/105221617X15093707969658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,21]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,3,21]]}},"alternative-id":["1052-2166(20180321)18:1L.5;1-"],"URL":"https:\/\/doi.org\/10.3727\/105221617x15093707969658","relation":{},"ISSN":["1052-2166"],"issn-type":[{"value":"1052-2166","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3,21]]}}}